PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Teladoc Health, Inc. (TDOC)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS87918A1051
CUSIP87918A105
SectorHealthcare
IndustryHealth Information Services

Highlights

Market Cap$2.20B
EPS-$1.34
PEG Ratio-1.01
Revenue (TTM)$2.60B
Gross Profit (TTM)$1.66B
EBITDA (TTM)$46.22M
Year Range$12.86 - $30.41
Target Price$19.70
Short %14.20%
Short Ratio5.01

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Teladoc Health, Inc.

Popular comparisons: TDOC vs. TRUP, TDOC vs. ^GSPC, TDOC vs. XLV, TDOC vs. SQ, TDOC vs. VOO, TDOC vs. AAPL, TDOC vs. QQQ, TDOC vs. SCHG, TDOC vs. SPY, TDOC vs. META

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Teladoc Health, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-50.00%0.00%50.00%100.00%150.00%NovemberDecember2024FebruaryMarchApril
-53.23%
143.01%
TDOC (Teladoc Health, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Teladoc Health, Inc. had a return of -38.14% year-to-date (YTD) and -48.27% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-38.14%5.84%
1 month-11.43%-2.98%
6 months-17.15%22.02%
1 year-48.27%24.47%
5 years (annualized)-25.45%11.44%
10 years (annualized)N/A10.46%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-9.84%-22.39%0.13%
2023-17.89%-11.03%9.67%18.80%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of TDOC is 10, indicating that it is in the bottom 10% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.

The Risk-Adjusted Performance Rank of TDOC is 1010
Teladoc Health, Inc.(TDOC)
The Sharpe Ratio Rank of TDOC is 88Sharpe Ratio Rank
The Sortino Ratio Rank of TDOC is 99Sortino Ratio Rank
The Omega Ratio Rank of TDOC is 1010Omega Ratio Rank
The Calmar Ratio Rank of TDOC is 1919Calmar Ratio Rank
The Martin Ratio Rank of TDOC is 66Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Teladoc Health, Inc. (TDOC) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


TDOC
Sharpe ratio
The chart of Sharpe ratio for TDOC, currently valued at -0.89, compared to the broader market-2.00-1.000.001.002.003.004.00-0.89
Sortino ratio
The chart of Sortino ratio for TDOC, currently valued at -1.35, compared to the broader market-4.00-2.000.002.004.006.00-1.35
Omega ratio
The chart of Omega ratio for TDOC, currently valued at 0.83, compared to the broader market0.501.001.500.83
Calmar ratio
The chart of Calmar ratio for TDOC, currently valued at -0.52, compared to the broader market0.002.004.006.00-0.52
Martin ratio
The chart of Martin ratio for TDOC, currently valued at -1.49, compared to the broader market0.0010.0020.0030.00-1.49
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.05, compared to the broader market-2.00-1.000.001.002.003.004.002.05
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.98, compared to the broader market-4.00-2.000.002.004.006.002.98
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.36, compared to the broader market0.501.001.501.36
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.55, compared to the broader market0.002.004.006.001.55
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 8.05, compared to the broader market0.0010.0020.0030.008.05

Sharpe Ratio

The current Teladoc Health, Inc. Sharpe ratio is -0.89. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2024FebruaryMarchApril
-0.89
2.05
TDOC (Teladoc Health, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Teladoc Health, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2024FebruaryMarchApril
-95.47%
-3.92%
TDOC (Teladoc Health, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Teladoc Health, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Teladoc Health, Inc. was 95.59%, occurring on Apr 19, 2024. The portfolio has not yet recovered.

The current Teladoc Health, Inc. drawdown is 95.47%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-95.59%Feb 9, 2021804Apr 19, 2024
-72.72%Aug 5, 2015162Mar 28, 2016310Jun 19, 2017472
-50.34%Oct 1, 201859Dec 24, 2018259Jan 6, 2020318
-30.86%Aug 5, 202069Nov 10, 202049Jan 22, 2021118
-24.19%Sep 15, 201744Nov 15, 201710Nov 30, 201754

Volatility

Volatility Chart

The current Teladoc Health, Inc. volatility is 10.66%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%35.00%NovemberDecember2024FebruaryMarchApril
10.66%
3.60%
TDOC (Teladoc Health, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Teladoc Health, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items